KIR3DL1 and neoplasm: Mature NK cells that express inhibitory KIRs mediate reduced tumor-targeted direct killing or ADCC when the KIRs interact with their respective HLA molecules (KIR-ligands; refer to Supplementary Tables S3 and S4) present on the tumor [13, 31].